Agios Pharmaceuticals
AGIO
#5076
Rank
A$2.46 B
Marketcap
A$42.33
Share price
0.89%
Change (1 day)
-24.05%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: A$2.46 Billion

As of January 2026 Agios Pharmaceuticals has a market cap of A$2.46 Billion. This makes Agios Pharmaceuticals the world's 5076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.46 B1.18%
2025A$2.43 B-20.34%
2024A$3.06 B67.62%
2023A$1.82 B-19.42%
2022A$2.26 B-7.92%
2021A$2.46 B-36.91%
2020A$3.90 B-16.34%
2019A$4.66 B22.42%
2018A$3.81 B6.73%
2017A$3.57 B46.78%
2016A$2.43 B-27.6%
2015A$3.35 B-33.86%
2014A$5.07 B506.25%
2013A$0.83 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

A$2.46 Billion
by Nasdaq info icon info icon
A$2.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
A$1.47 B-40.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$17.66 B 615.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$215.83 B 8,644.63%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$16.87 B 583.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$151.72 B 6,047.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
A$1.420 T 57,450.45%๐Ÿ‡บ๐Ÿ‡ธ USA